Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis, HIV and the developing world.

B Gazzard1

  • 1Chelsea and Westminster Hospital, London. eileen.witney@chelwest.org

Clinical Medicine (London, England)
|May 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The EuroSIDA study: 25 years of scientific achievements.

HIV medicine·2019
Same author

Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Journal of neurovirology·2018
Same author

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.

Journal of neurovirology·2017
Same author

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.

International journal of STD & AIDS·2016
Same author

Editorial.

HIV medicine·2016
Same author

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.

PloS one·2015
Same journal

Resident doctor workforce wellbeing worldwide: lessons between the United Kingdom and Australia.

Clinical medicine (London, England)·2026
Same journal

Premature ventricular complexes.

Clinical medicine (London, England)·2026
Same journal

Heart failure with preserved ejection fraction (HFpEF): diagnosis and management for the general physician.

Clinical medicine (London, England)·2026
Same journal

Trends and Widening Inequities in Cardiovascular-Kidney-Metabolic Involvement in Cardiovascular Mortality: A National Spatiotemporal Analysis, 2014-2023.

Clinical medicine (London, England)·2026
Same journal

Educating current and future healthcare professionals on evidence-based sustainable medicine.

Clinical medicine (London, England)·2026
Same journal

UK Foundation Programme training needs a national minimum standard for advanced life support.

Clinical medicine (London, England)·2026
See all related articles

The human immunodeficiency virus (HIV) epidemic has worsened tuberculosis (TB) globally, particularly in developing nations. Effective control requires a coordinated worldwide effort, addressing both immunology and treatment adherence for these major infectious diseases.

Area of Science:

  • Immunology
  • Genetics
  • Epidemiology
  • Infectious Diseases

Background:

  • The human immunodeficiency virus (HIV) epidemic has significantly amplified the global tuberculosis (TB) pandemic.
  • Coinfection rates of HIV and TB are high, especially in developing countries, increasing susceptibility and disease dissemination.
  • Effective antiretroviral therapy in developed nations complicates the understanding of TB's impact on the HIV epidemic.

Purpose of the Study:

  • To review the immunology, genetics, epidemiology, and treatment of HIV and TB.
  • To highlight the synergistic impact of HIV and TB coinfection on global public health.
  • To discuss challenges and strategies for controlling these two major infectious diseases.

Main Methods:

Related Experiment Videos

  • Review of existing literature on HIV and TB.
  • Analysis of epidemiological data on coinfection rates and disease impact.
  • Examination of immunological and genetic factors influencing disease progression.
  • Evaluation of treatment strategies and adherence challenges.

    • Main Results:

    • HIV exacerbates TB, leading to premature deaths in resource-poor settings.
    • Both infections involve immunologically competent cells and have a significant genetic component.
    • Treatment challenges for both diseases include drug resistance and poor patient adherence.
    • Global control necessitates a significant mobilization of resources.

    Conclusions:

    • HIV and TB coinfection pose a critical global public health challenge.
    • Understanding the complex interplay of immunology, genetics, and treatment is crucial.
    • Effective control strategies require international cooperation and resource allocation.